Cyclotek
Melbourne, Australia· Est.
Australian PET radiopharma supplier with a national cyclotron network and proprietary tracer portfolio.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Australian PET radiopharma supplier with a national cyclotron network and proprietary tracer portfolio.
OncologyNeurologyCardiology
Technology Platform
Cyclotron‑based production of PET isotopes (e.g., 18F, 161Tb) combined with proprietary synthesis chemistry to generate diagnostic and theranostic tracers.
Opportunities
Expansion of APAC PET imaging services, development of novel theranostic tracers, and strategic collaborations to broaden market reach.
Risk Factors
Regulatory hurdles for new radiopharmaceuticals, isotope supply chain volatility, and competition from global radiopharma manufacturers.
Competitive Landscape
Competes with international PET radiopharma firms such as Cardinal Health, GE Healthcare, IBA and Siemens, differentiating through a regional cyclotron network, proprietary tracer development and integrated logistics.